三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > IBI302：全球首个眼用抗VEGF/补体的双特异性融合蛋白
图片属性
图片格式：PNG 图片大小：1044KB 图片尺寸：1755*874
同报告图片
 / 4
IBI302：全球首个眼用抗VEGF/补体的双特异性融合蛋白_第1页
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
IBI302：全球首个眼用抗VEGF/补体的双特异性融合蛋白_第2页
fCDoja/lk4HlkI3np7AgfCDmlrnmoYggfCDkuK3lm73ojrfmibnml6XmnJ8gfCDmibnlh4bnsbvlnosgfCDpgILlupTnl4cgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg5ZCJ6KW/5LuW5ruoIHwg5ZCJ6KW/5LuW5ruoIHwgMjAwMi0wMS0wMSB8IOW4uOinhOaJueWHhiB8IOWxgOmDqOaZmuacn+aIluW3sui9rOenu+eahOiDsOiFuueZjO+8m+mZpOmdnuS4tOW6iuS4iuacieemgeW/jO+8jOWQpuWImeaXouW+gOWMlueWl+S4reW6lOS9v+eUqOi/h+iSveeOr+exu+aKl+eUn+e0oOOAgiB8Cnwg5bC85aal54+g5Y2V5oqXIHwg6IGU55So5ZCJ6KW/5LuW5ruoIHwgMjAyMy0wNi0xMiB8IOW4uOinhOaJueWHhiB8IOeUqOS6juayu+eWl+iDsOiFuueZjOaCo+iAheOAgiB8Cnwg55m96JuL55m957Sr5p2J6YaHIHwg6IGU55So5ZCJ6KW/5LuW5ruoIHwgMjAyNC0wMS0wNSB8IOW4uOinhOaJueWHhiB8IOiBlOWQiOWQieilv+S7lua7qOS4gOe6v+ayu+eWl+iDsOiFuueZjCB8Cnwg6KGo5p+U5q+U5pifIHwg6KGo5p+U5q+U5pifIHwgMjAwNi0wMy0wMSB8IOW4uOinhOaJueWHhiB8IOayu+eWl+aBtuaAp+a3i+W3tOeYpOOAgeS5s+iFuueZjOOAgeiCuueZjOOAgei9r+e7hOe7h+iCieeYpOOAgemjn+mBk+eZjOOAgeiDg+eZjOOAgeiCneeZjOOAgeiDsOiFuueZjOOAgem7keiJsue0oOeYpOOAgee7k+iCoOebtOiCoOeZjOOAgeWNteW3oueZjOOAgeWkmuWPkeaAp+mqqOmrk+eYpOOAgeeZveihgOeXheOAguiGgOiDseWGhee7meiNr+acieWKqeS6jua1heihqOaAp+iGgOiDseeZjOOAgeWOn+S9jeeZjOeahOayu+eWl+WSjOmihOmYsuWFtue7j+Wwv+mBk+WIh+mZpOacr+WQjueahOWkjeWPkeOAgiB8CnwgSFIwNzA4MDPvvIjkvIrnq4vmm7/lurfohILotKjkvZPvvIkgfCDogZTnlKg1LUZVK0xldWNvdm9yaW4gfCAyMDI0LTAxLTA1IHwg5bi46KeE5om55YeGIHwg6IGU5ZCI5rCf5bC/5Zin5ZW2KDUtRlUp5ZKM5Lqa5Y+26YW46ZKZKExWKe+8jOeUqOS6juaXouW+gOe7j+WQieilv+S7lua7qOS4uuWfuuehgOeahOWMliDnlpfmsrvnlpflpLHotKXnmoTkuI3lj6/liIfpmaTnmoTlsYDpg6jmmZrmnJ/miJbovaznp7vmgKfog7DohbrnmYzmgqPogIXnmoTmsrvnlpfjgIIgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5b636YKm56CU56m25omA
IBI302：全球首个眼用抗VEGF/补体的双特异性融合蛋白_第3页
IBI302：全球首个眼用抗VEGF/补体的双特异性融合蛋白_第4页
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
IBI302：全球首个眼用抗VEGF/补体的双特异性融合蛋白_第5页
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
所属报告： 信达生物-港股公司研究报告：新时代Pharma代表创新药全领域旗舰-241024（52页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询商务合作事宜
copyright@2008-2013 长沙思想领动信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备2023027541号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠